High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$444K
$444,097
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ALLO
S
Allogene Therapeutics, Inc.
Beneski Benjamin Machinas
• Officer • SVP, Chief Technical Officer
Sell to Cover
2026-03-02
$18,543
|
||||||
| ALLO |
Allogene Therapeutics, Inc.
|
Officer • SVP, Chief Technical Officer
Sell to Cover
|
2026-03-02 | $18,543 | S | Form 4 |
|
ALLO
S
Allogene Therapeutics, Inc.
Beneski Benjamin Machinas
• Officer • SVP, Chief Technical Officer
Sell to Cover
2026-02-02
$13,060
|
||||||
| ALLO |
Allogene Therapeutics, Inc.
|
Officer • SVP, Chief Technical Officer
Sell to Cover
|
2026-02-02 | $13,060 | S | Form 4 |
| ALLO |
Allogene Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-02-02 | $171,484 | S | Form 4 |
|
ALLO
S
Allogene Therapeutics, Inc.
Douglas Earl Martin
• Officer • SVP, General Counsel
Sell to Cover
2026-02-02
$40,304
|
||||||
| ALLO |
Allogene Therapeutics, Inc.
|
Officer • SVP, General Counsel
Sell to Cover
|
2026-02-02 | $40,304 | S | Form 4 |
| ALLO |
Allogene Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-02-02 | $42,242 | S | Form 4 |
|
ALLO
S
Allogene Therapeutics, Inc.
Roberts Zachary
• Officer • EVP of R&D
Sell to Cover
2026-02-02
$63,189
|
||||||
| ALLO |
Allogene Therapeutics, Inc.
|
Officer • EVP of R&D
Sell to Cover
|
2026-02-02 | $63,189 | S | Form 4 |
|
ALLO
S
Allogene Therapeutics, Inc.
Yoshiyama Annie
• Officer • SVP, Finance
Sell to Cover
2026-02-02
$7,167
|
||||||
| ALLO |
Allogene Therapeutics, Inc.
|
Officer • SVP, Finance
Sell to Cover
|
2026-02-02 | $7,167 | S | Form 4 |
|
ALLO
S
Allogene Therapeutics, Inc.
Roberts Zachary
• Officer • EVP of R&D
Sell to Cover
2026-01-21
$40,980
|
||||||
| ALLO |
Allogene Therapeutics, Inc.
|
Officer • EVP of R&D
Sell to Cover
|
2026-01-21 | $40,980 | S | Form 4 |
| ALLO |
Allogene Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-18 | $0 | M | Form 4 |
|
ALLO
S
Allogene Therapeutics, Inc.
Beneski Benjamin Machinas
• Officer • SVP, Chief Technical Officer
Sell to Cover
2025-11-17
$959
|
||||||
| ALLO |
Allogene Therapeutics, Inc.
|
Officer • SVP, Chief Technical Officer
Sell to Cover
|
2025-11-17 | $959 | S | Form 4 |
| ALLO |
Allogene Therapeutics, Inc.
|
CFO
Sell to Cover
|
2025-10-21 | $46,169 | S | Form 4 |